Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial - Journal of Thoracic Oncology
,%20Carcinoma,%20Non-Small-Cell%20Lung:%0A%0ALW-02%20device%20immunopheresis%20combined%20with%20atezolizumab%20for%20Lung%20Cancer.png?md=1 "LW-02 device immunopheresis combined with atezolizumab for Lung Cancer Clinical Trial | Power")
LW-02 device immunopheresis combined with atezolizumab for Lung Cancer Clinical Trial | Power
IMPower133 Clinical Trial Design for ES-SCLC | TECENTRIQ® (atezolizumab)
Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials - European Journal of Cancer
A clinical trial to compare atezolizumab with a placebo in people with head and neck cancer who are at a high risk of their cancer returning or getting worse after completion of
Atezolizumab for Urinary Bladder Cancer Clinical Trial | Power
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | NEJM
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial - Clinical Lung Cancer
Anti-PD-L1 antibodies atezolizumab, avelumab and durvalumab currently... | Download Scientific Diagram
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC | NEJM
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial | Nature Medicine
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial - European Urology
Profile of atezolizumab in the treatment of metastatic non-small-cell | DDDT
IMpower150, IMpower110, & OAK Clinical Trial Designs | TECENTRIQ® ( atezolizumab)
Atezolizumab - Wikipedia
FLASCO / Atezolizumab Clinical Trials
Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China | Journal of Hematology & Oncology | Full Text
